VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...
The effect of chronic breathlessness on the lives of patients and their loved ones is tremendous, regardless of the ...
Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback